Oncologist. 2016 May 5. pii: theoncologist.2016-0030. [Epub ahead of print]
Comprehensive Genomic Profiling Facilitates Implementation of the National Comprehensive Cancer Network Guidelines for Lung Cancer Biomarker Testing and Identifies Patients Who May Benefit From Enrollment in Mechanism-Driven Clinical Trials.
Suh JH1, Johnson A2, Albacker L2, Wang K3, Chmielecki J2, Frampton G2, Gay L2, Elvin JA2, Vergilio JA2, Ali S2, Miller VA2, Stephens PJ2, Ross JS2.
IMPLICATIONS FOR PRACTICE:
Clinical trials; Comprehensive genomic profiling; National Comprehensive Cancer Network guidelines; Non-small cell lung cancer
- [PubMed - as supplied by publisher]